Against the odds, GSK has secured FDA approval for its multiple myeloma therapy Blenrep, three years after it was removed from sale. Anti-BCMA antibody-drug conjugate (ADC) Blenrep (belantamab ...
The hardware and software changes should perk up decision makers at border agencies, forensic laboratories and central banks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results